Protalix BioTherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $77.9M | $51.8M | $27.0M |
| FY2012 | $82.1M | $78.7M | $52.0M |
| FY2013 | $140.3M | $113.3M | $86.4M |
| FY2014 | $134.0M | $78.4M | $54.8M |
| FY2015 | $86.4M | $97.3M | $76.4M |
| FY2016 | $92.2M | $82.2M | $63.3M |
| FY2017 | $101.7M | $72.2M | $51.2M |
| FY2018 | $114.0M | $61.1M | $37.8M |
| FY2019 | $115.7M | $45.4M | $17.8M |
| FY2020 | $95.0M | $67.9M | $18.3M |
| FY2021 | $79.7M | $73.7M | $39.0M |
| FY2022 | $66.4M | $55.8M | $17.1M |
| FY2023 | $50.9M | $84.4M | $23.6M |
| FY2024 | $30.2M | $73.4M | $19.8M |
| FY2025 | $34.1M | $82.3M | $14.7M |